Wedbush Raises Nuvalent (NASDAQ:NUVL) Price Target to $115.00
Nuvalent (NASDAQ:NUVL – Free Report) had its target price boosted by Wedbush from $99.00 to $115.00 in a research report released on Monday, Benzinga reports. Wedbush currently has an outperform rating on the stock. Several other brokerages have also weighed in on NUVL. Guggenheim upped their target price on shares of Nuvalent from $99.00 to […]
20 Sep 07:46 · The Markets Daily